Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes
- 8 September 2015
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (S3) , 766-771
Abstract
Background Metformin use has been associated with a dose-dependent increased response to neoadjuvant chemo(radio)therapy in esophageal cancer patients. However, no association between metformin use...Keywords
This publication has 26 references indexed in Scilit:
- Case–control analysis on metformin and cancer of the esophagusCancer Causes & Control, 2013
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysisPLOS ONE, 2012
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysisCancer Prevention Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?Molecular Cancer Therapeutics, 2010
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer, 1998